Jeremy’s whole career has been dedicated to protecting and improving global health. As a researcher he specialised in infectious diseases, and he has published more than 600 papers. As part of the response to the Covid-19 pandemic, Jeremy is a member of the UK Vaccine Taskforce and the Principles Group of the ACT-Accelerator hosted by the World Health Organization (WHO), and he chairs the WHO R&D Blueprint Advisory Group. As well as sharing his expertise, he champions rapid investment in research on Covid-19 testing, treatments and vaccines, and argues that everyone – not only people who live in rich countries – should benefit equally from the discoveries that result.